Jennifer Chien - Net Worth and Insider Trading
Jennifer Chien Net Worth
The estimated net worth of Jennifer Chien is at least $375,010 dollars as of 2024-11-05. Jennifer Chien is the EVP, Head of North America of Rhythm Pharmaceuticals Inc and owns about 6,852 shares of Rhythm Pharmaceuticals Inc (RYTM) stock worth over $375,010. Details can be seen in Jennifer Chien's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jennifer Chien has not made any transactions after 2024-03-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jennifer Chien
Jennifer Chien Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jennifer Chien owns 2 companies in total, including Krystal Biotech Inc (KRYS) , and Rhythm Pharmaceuticals Inc (RYTM) .
Click here to see the complete history of Jennifer Chien’s form 4 insider trades.
Insider Ownership Summary of Jennifer Chien
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KRYS | Krystal Biotech Inc | 2020-01-20 | Chief Commercial Officer |
| RYTM | Rhythm Pharmaceuticals Inc | 2024-03-20 | EVP & Head of North America |
Jennifer Chien Latest Holdings Summary
Jennifer Chien currently owns a total of 1 stock. Jennifer Chien owns 6,852 shares of Rhythm Pharmaceuticals Inc (RYTM) as of March 20, 2024, with a value of $375,010.
Latest Holdings of Jennifer Chien
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RYTM | Rhythm Pharmaceuticals Inc | 2024-03-20 | 6,852 | 54.73 | 375,010 |
Holding Weightings of Jennifer Chien
Jennifer Chien Form 4 Trading Tracker
According to the SEC Form 4 filings, Jennifer Chien has made a total of 13 transactions in Rhythm Pharmaceuticals Inc (RYTM) over the past 5 years, including 0 buys and 13 sells. The most-recent trade in Rhythm Pharmaceuticals Inc is the sale of 18,235 shares on March 20, 2024, which brought Jennifer Chien around $706,971.
Insider Trading History of Jennifer Chien
- 1
Jennifer Chien Trading Performance
Jennifer Chien Ownership Network
Ownership Network List of Jennifer Chien
Ownership Network Relation of Jennifer Chien
Jennifer Chien Owned Company Details
What does Krystal Biotech Inc do?
Who are the key executives at Krystal Biotech Inc?
Jennifer Chien is the Chief Commercial Officer of Krystal Biotech Inc. Other key executives at Krystal Biotech Inc include director & 10 percent owner & President and CEO Krish S Krishnan , director & 10 percent owner & Chief Operating Officer Suma Krishnan , and Chief Accounting Officer Kathryn Romano .
Krystal Biotech Inc (KRYS) Insider Trades Summary
Over the past 18 months, Jennifer Chien made no insider transaction in Krystal Biotech Inc (KRYS). Other recent insider transactions involving Krystal Biotech Inc (KRYS) include a net sale of 300,000 shares made by Suma Krishnan , a net sale of 300,000 shares made by Krish S Krishnan , and a net sale of 76,515 shares made by Kathryn Romano .
In summary, during the past 3 months, insiders sold 100,000 shares of Krystal Biotech Inc (KRYS) in total and bought 0 shares, with a net sale of 100,000 shares. During the past 18 months, 826,115 shares of Krystal Biotech Inc (KRYS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 826,115 shares.
Krystal Biotech Inc (KRYS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Krystal Biotech Inc Insider Transactions
Jennifer Chien Mailing Address
Above is the net worth, insider trading, and ownership report for Jennifer Chien. You might contact Jennifer Chien via mailing address: C/o Krystal Biotech, Inc., 2100 Wharton Street, Suite 701, Pittsburgh Pa 15203.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
